DOI:

10.37988/1811-153X_2024_3_52

Influence of intracanal drug therapy on the content of proinflammatory interleukins in root canal exudate in teeth with experimental apical periodontitis

Authors

  • A.P. Pedorets 1, Doctor of Science in Medicine, full professor of the Therapeutic dentistry Department
    ORCID: 0009-0006-5989-0492
  • A.G. Pilyaev 1, PhD in Medical Sciences, associate professor of the Therapeutic dentistry Department
    ORCID: 0009-0009-1691-9808
  • V.A. Klyomin 1, Doctor of Science in Medicine, full professor of the Prosthodontics Department
    ORCID: 0000-0001-7853-7236
  • O.V. Shabanov 1, assistant in the Therapeutic dentistry Department
    ORCID: 0009-0001-0977-2969
  • S.I. Maksyutenko 1, PhD in Medical Sciences, associate professor and head of the General Dentistry Department
    ORCID: 0009-0006-3578-1144
  • 1 Donetsk State Medical University, 283003, Donetsk, Russia

Abstract


Material and methods.
The content of proinflammatory interleukins IL-1β and TNF-α in the exudate of the root canal of teeth with preserved and artificially destroyed apical orifice (AO) in the modeling of experimental periodontitis on 12 premolars of the lower jaw of dogs was studied in this work. Interleukins (IL-1β and TNF-α) were determined in root canal exudate by enzyme immunoassay. The dynamics of interleukin content changes after intracanal medical therapy with the calcium hydroxide-based preparation Calasept was analyzed separately in teeth with preserved and artificially destroyed apical foramen.
Results.
The mean IL-1β content in root canal exudate of teeth with destroyed AO was 5.56±0.96 pg/mL, which was significantly higher (p<0.05) than in teeth with preserved apical orifice (2.83±0.43 pg/mL). TNF-α content was not different in teeth with preserved and destroyed AO (p>0.05). Despite significant differences in mean values, IL-1β content was not obligatorily related to AO status (χ2=0.34; p=0.59). As a result of intracanal therapy, in teeth with preserved AO, IL-1β content was 1.41±0.68 pg/mL, which was significantly lower than baseline (t=1.76; p<0.05). In teeth with artificially destroyed AO the IL-1β content was 6.16±1.02 pg/mL, practically did not differ (t=0.43; p>0.05).
Conclusions.
The decrease of IL-1β content in root canal exudate after intracanal medical therapy may be an indirect evidence of the effectiveness of endodontic treatment only in teeth with preserved AO. In teeth with destroyed AO, intracanal medical therapy was not obligatorily associated with a reduction in the inflammatory response in the periodontium.

Key words:

periodontitis, the apical opening of the tooth root, IL-1β, TNF-α, intracanal drug therapy

For Citation

[1]
Pedorets A.P., Pilyaev A.G., Klyomin V.A., Shabanov O.V., Maksyutenko S.I. Influence of intracanal drug therapy on the content of proinflammatory interleukins in root canal exudate in teeth with experimental apical periodontitis. Clinical Dentistry (Russia).  2024; 27 (3): 52—58. DOI: 10.37988/1811-153X_2024_3_52

References

  1. Ricucci D. Endodontology An integrated biological and clinical view.— Cetraro: Quintessence, 2013. Pp. 107, 109, 115; pp. 155, 156; pp. 147, 149, 150.
  2. Karamifar K., Tondari A., Saghiri M.A. Endodontic Periapical Lesion: An Overview on the Etiology, Diagnosis and Current Treatment Modalities. Eur Endod J. 2020; 5 (2): 54—67. PMID: 32766513
  3. Takahama A. Jr, Rôças I.N., Faustino I.S.P., Alves F.R.F., Azevedo R.S., Gomes C.C., Araújo-Filho W.R., Siqueira J.F. jr Association between bacteria occurring in the apical canal system and expression of bone-resorbing mediators and matrix metalloproteinases in apical periodontitis. Int Endod J. 2018; 51 (7): 738—746. PMID: 29363148
  4. Yurovskaya I.A., Pedorets A.P., Pilyaev A.G., Barkalova E.I. Periapical resorbtion of root cementum and its connection with the pathohistological picture of chronic periodontitis. Archives of Clinical and Experimental Medicine. 2011; 1: 62—67 (In Russian). eLIBRARY ID: 20160456
  5. Pedorets A.P., Belous A.P., Isakova N.A., Pilyayev A.G. Histological and scanning electron study of root apical resorption in experimental apical periodontitis. Archives of Clinical and Experimental Medicine. 2012; 1: 92—96 (In Russian). eLIBRARY ID: 19596812
  6. Braz-Silva P.H., Bergamini M.L., Mardegan A.P., De Rosa C.S., Hasseus B., Jonasson P. Inflammatory profile of chronic apical periodontitis: a literature review. Acta Odontol Scand. 2019; 77 (3): 173—180. PMID: 30585523
  7. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009; 27: 519—50. PMID: 19302047
  8. Tazawa K., Azuma Presse M.M., Furusho H., Stashenko P., Sasaki H. Revisiting the role of IL-1 signaling in the development of apical periodontitis. Front Dent Med. 2022; 3: 985558. PMID: 36938490
  9. Sarmento E.B., Gomes C.C., Pires F.R., Pinto L.C., Antunes L.A.A., Armada L. Immunoexpression of bone resorption biomarkers in apical periodontitis in diabetics and normoglycaemics. Int Endod J. 2020; 53 (8): 1025—1032. PMID: 32271943
  10. Pedorets A.P., Shabanov O.V., Piliaiev A.G., Maksiutenko S.I., Terpigoreva L.P. The content of proinflammatory cytokines in the periapical exudate in teeth with different clinical course of chronic apical periodontitis. University Clinic. 2022; 3 (44): 38—42 (In Russian). eLIBRARY ID: 49842400
  11. Jakovljevic A., Knezevic A., Karalic D., Soldatovic I., Popovic B., Milasin J., Andric M. Pro-inflammatory cytokine levels in human apical periodontitis: Correlation with clinical and histological findings. Aust Endod J. 2015; 41 (2): 72—7. PMID: 25163634
  12. Luo X., Wan Q., Cheng L., Xu R. Mechanisms of bone remodeling and therapeutic strategies in chronic apical periodontitis. Front Cell Infect Microbiol. 2022; 12: 908859. PMID: 35937695

Received

February 13, 2024

Accepted

August 16, 2024

Published on

October 2, 2024